Evidence map›Paper›PMID 34694760›Full record

ArticleIET nanobiotechnology2021

Anti-inflammatory ethosomal nanoformulation in combination with iontophoresis in chronic wound healing: An ex vivo study.

Reza Mombeiny, Shima Tavakol, Mostafa Kazemi, Mehdi Mehdizadeh, Akbar Hasanzadeh, Mohammad Karimi Babaahmadi, Ali Abedi, Peyman Keyhanvar

Abstract read
In one paragraph

Article in IET nanobiotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Reza MombeinyNanotechnology Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Shima TavakolCellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0002-8531-7650
Mostafa KazemiCellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.
Mehdi MehdizadehCellular and Molecular Research Center, Faculty of Advanced Technologies in Medicine, Department of Anatomy, Iran University of Medical Sciences, Tehran, Iran.
Akbar HasanzadehCellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.
Mohammad Karimi BabaahmadiDepartment of Medical Biotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
Ali AbediDepartment of Life Sciences Engineering, Faculty of New Sciences and Technology, University of Tehran, Tehran, Iran.
Peyman KeyhanvarCellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.

Funding

Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran 94-04-87-26881
6 · The paper itself

Abstract

Prescription of anti-inflammatory drugs may be considered as a promising strategy in chronic wound healing where the inflammatory disturbance has delayed the healing process. It seems that hydrocortisone 17-butyrate (HB17) would be promising in the form of a nano-formulation to enhance drug delivery efficacy. In the present study, transdermal delivery of nano-HB17 in combination with iontophoresis was investigated ex vivo. Ethosomal-HB17 was synthesised using lecithin, ethanol and cholesterol with a different ratio by hot method. The negative ethosomal-HB17 particle size was around 244 ± 4.3 nm with high stability of up to 30 days. Additionally, evaluated entrapment efficiency of HB17 in ethosomes by high performance liquid chromatography was 40.6 ± 2.21%. Moreover, the permeation speed and amount of H17B in complete-thickness rat skin in the presence and absence of iontophoresis showed that the penetration of free H17B and ethosomal-H17B formulations were zero and 7.98 μg/cm

Indexed as

IontophoresisSkin AbsorptionAdministration, CutaneousAnimalsAnti-Inflammatory AgentsLiposomesRatsSkinWound HealingAnti-Inflammatory AgentsLiposomeschronic wound healingethosomehydrocortisone 17-butyratenano-carriernanoparticletransdermal delivery

Identifiers

PMID34694760
PMCPMC8806119

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.